期刊文献+

志贺菌质粒介导喹诺酮类耐药基因研究 被引量:2

Study on genotypes of plasmid-mediated quinolone in Shigella
原文传递
导出
摘要 目的了解志贺菌中质粒介导喹诺酮类耐药基因qnrA、qnrB、qnrS和aac(6’).Ib-cr的流行情况以及其耐药特征。方法PCR法对57株志贺菌进行qnrA、qnrB、qnrS和aac(6’)-Ib基因检测,PCR扩增阳性菌株进行测序和基因分型,并与大肠埃希菌J53作接合试验,采用琼脂稀释法检测志贺菌和接合前后大肠埃希菌J53对抗菌药物的最小抑菌浓度(MIC);特异性PCR扩增确认接合子基因型。结果57株志贺菌中,筛选出qnrS、qnrB阳性株各1株(ZH13和ZH53),均为福氏志贺菌,其基因序列在NCBI成功登录,登录号分别为FJ616991和FJ616990,未检出qnrA和aac(6’)-Ib基因;其中ZH13接合试验成功,ZH53不能接合,接合试验后的大肠埃希菌J53对多种抗菌药物的MIC明显提高;特异性PCR证实接合子和供体菌有相同的qnr基因。结论在志贺菌中检出qnrS基因,且国内首次检出qnrB基因,qnr阳性菌株呈多重耐药,且其耐药性可以通过接合方式发生水平转移,需加强监控。 Objective To investigate the prevalence of qnrA, qnrB, qnrS and aac (6')- I b-cr genes in Shigella isolates and their characterization of resistance. Methods qnrA, qnrB, qnrS and aac (6')- I b genes in 57 isolates of Shigella were detected by PCR, DNA sequencing and genotyping were per- formed. PCR positive strains, conjugation test was performed and E. coli J53 as receptor. Minimum inhibi- tory concentration(MIC) of ShigeUa and E. coli J53 before and after conjugation test were determined by agar dilution method. PCR were used to determine the genotype of eonjugon. Results The qnrS and qnrB genes were identified in two isolates( ZH13 and ZH53 ) , and all were Shigellaflexneri. The sequence acces- sion number in NCBI database are FJ616991, FJ616990 separately, qnrA and aac(6')- I b-cr genes were not found in all isolates. ZH13 conjugation were successful, and ZH53 repetitive conjugation were unsuc- cessful, the MIC of E. coli J53 were increased evidently after conjugation. The qnr genotype of conjugon was similar to donator. Conclusion We identified qnrS gene in Shigella flexneri strains, and identified qnrB gene in Shigellaflexneri in China for the first time. The qnr gene positive strains were multiplex resistant and the resistance of these strains could be transfered, so it should be monitored carefully.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2009年第8期691-694,共4页 Chinese Journal of Microbiology and Immunology
基金 基金项目:温州市科技局资助项目(Y20080018)
关键词 志贺菌 喹诺酮类 QNR aac(6’)-I b-cr 基因型 Shigella Quinolone qnr aac(6')-I b-cr Genotype
  • 相关文献

参考文献16

  • 1Turner SA, Luck SN, Sakellaris H, et al. Role of attP in integrase mediated intergration of the Shigella resistance locus pathogenicty island of Shigella flexneri. Antimicrob Agents Chemother, 2004, 48(3) : 1028-1031.
  • 2Acar JF, Goldstein FW. Trends in bacterial resistance to fluoroquinalones. Clin Infect Dis, 1997, 24 Suppl 1: S67-73.
  • 3Clinical and Laboratory Stardards Institute. Performance standards for antimicrobial susceptibility testing. CLSI document M100-S18. wayne, Pennsylvania. 2008, 28( 1 ) : 1-181.
  • 4Lee JK, Lee YS, Park YK, et al. Alterations in the GyrA and GyrB subunits of topoisomerase II and the ParC and ParE subunits of topoisomerase IV in ciprofloxacin-resistant clinical isolates of Pseudomonas aeruginosa, lnt J Antimicrob Agents, 2005, 25 (4) :290-295.
  • 5唐传玲,朱于莉,汪萱怡,赵守军,瞿涤.福氏志贺菌喹诺酮类耐药临床分离株gyrA和parC的基因突变[J].中华传染病杂志,2005,23(3):150-153. 被引量:5
  • 6Poirel L, Van De Loo M, Mammeri H, et al. Association of plasmid-mediated quinolone resistance with extended-spectrum betalactamase VEB-1. Antimicrob Agents Chemother, 2005, 49 (7) : 3091-3094.
  • 7Jacoby GA, Walsh KE, Mills DM, et al. qnrB, another plasmidmediated gene for quinolone resistance. Antimicrob Agents Chemother, 2006, 50(4) : 1178-1152.
  • 8Wu JJ, Ko WC, Tsai SH, et al. Prevalence of plasmid-mediated quinolone resistance determinants QnrA, QnrB, and QnrS among clinical isolates of Enterobacter cloacae in a Taiwan Residents hospital. Antimicrob Agents Chemother, 2007, 51 (4) : 1223-1227.
  • 9Park CH, Robicsek A, Jacoby GA, et al. Prevalence in the United States of aac ( 6' ) - I b-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother, 2006, 50 ( 11 ) : 3953- 3955.
  • 10Wang M, Tran JH, Jacoby GA, et al. Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother, 2003, 47 (7) : 2242- 2248.

二级参考文献22

  • 1熊自忠,朱德妹,汪复,张婴元.CTX-M-14和CTX-M-24编码基因的检测及其功能表达[J].中华医学杂志,2004,84(17):1454-1459. 被引量:15
  • 2李家斌,李旭,马亦林,俞云松.TEM-105编码基因的功能研究[J].中国药理学通报,2005,21(2):162-165. 被引量:6
  • 3李涛,熊自忠,沈继录,周强,徐元宏,王中新.大肠埃希菌与克雷伯菌属细菌qnr基因的检测[J].检验医学,2005,20(2):112-114. 被引量:35
  • 4F奥斯伯 颜子颖译.精编分子生物学实验指南[M].北京:科学出版社,1998.671.
  • 5Kotloff KL, Winickoff JP, Ivanoff B, et al. Global burden of Shigella infections:implications for vaccine development and implementation of control strategies. Bull World Health Organ, 1999,77:651-666.
  • 6Ruiz J. Mechanism of resistance to quinolones:target alterations, decreased accumulation and DNA gyrase protection. J Antimicrob Chemother, 2003,51:1109-1117.
  • 7Saenz Y, Ruiz J, Zarazaga M, et al. Effect of the efflux pump inhibitor Phe-Arg-β-naphthylamide on the MIC values of the quinolones, tetracycline and chloramphenicol, in Escherichia coli isolates of different origin. J Antimicrob Chemother, 2004, 53:544-545.
  • 8Ince D, Hooper DC. Quinolone resistance due to reduced target enzyme expression. J Bacteriol, 2003,185:6883-6892.
  • 9National Committee for Clinical Laboratory Standards. Performance standards for disk susceptibility testing;seventh edition:Approved Standard M2-A7. NCCLS, 2000, Wayne, PA, USA.
  • 10National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing;Thirteenth Informational supplement M100-S13. NCCLS, 2003 January, Villanova, PA, USA.

共引文献35

同被引文献23

  • 1朱静媛,段广才,范清堂.耐喹诺酮类福氏志贺菌基因突变分析[J].中国公共卫生,2004,20(2):154-156. 被引量:4
  • 2杨海燕,段广才,郗园林.主动外排系统acrAB在志贺菌中分布和表达[J].中国公共卫生,2005,21(6):685-687. 被引量:33
  • 3唐传玲,朱于莉,汪萱怡,赵守军,瞿涤.福氏志贺菌喹诺酮类耐药临床分离株gyrA和parC的基因突变[J].中华传染病杂志,2005,23(3):150-153. 被引量:5
  • 4游升荣,孙自镛,陈晶.志贺菌对氟喹诺酮的耐药机制及流行状况研究[J].中国卫生检验杂志,2006,16(3):283-285. 被引量:3
  • 5Thomson CJ. The global epidemiology of resistance to cipro- floxaein and the changing nature of antibiotic resistance: a 10 year perspective [J] .J Antimicrob Chemother, 1999, 43(Suppl A): 31-40.
  • 6Talukder KA, Khajanchi BK, Islam MA, et al. Fluoroquinolo- ne resistance kinked to both gyrA and parC mutations in the quinolone resistance determining region of Shigella dysenteriae type 1 EJ].Curr Microbiol, 2006, 52 (2): 108-111.
  • 7Hu LF, Li JB, Ye Y, et al. Mutations in the gyrA subunit of DNA gyrase and the parC subunit of topoisomerase IV in clini- cal strains of fluoroquinolone-resistant Shigella in Anhui, China EJ~-J Microbiol, 2007, 45 (2): 168-170.
  • 8Pazhani GP, Sarkar B, Ramamurthy T elonal multldrug-resist- ant shigella dysenteriae type 1 strains associated with epidemic and sporadic dysenteries in eastern Indial [J]. Antimicrob A- gents Chemother, 2004, 48 (2): 681 684.
  • 9Ahamed J, Gangopadhyay J, Kundu M, et al. Mechanisms of quinolone resistance in clinical isolates of Shigelladysenteriae [J].Antimicrob Agents Chemother , 1999 , 43 (9): 23332334.
  • 10Clinical and Laboratory Standards Institute. Performance stand- ards for antimicrobial susceptibility testing. CLSI document MIO0 S18. wayne [J].Pennsylvania, 2008, 28 (1): 1-181.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部